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Abstract
Background: Cellular cholesterol is a vital component of the cell membrane. Its concentration is tightly controlled by
mechanisms that remain only partially characterized. In this study, we describe a late endosome/lysosomes–associated
protein whose expression level affects cellular free cholesterol content.
Methodology/Principal Findings: Using a restricted proteomic analysis of detergent-resistant membranes (DRMs), we have
identified a protein encoded by gene C11orf59. It is mainly localized to late endosome/lysosome (LE/LY) compartment
through N-terminal myristoylation and palmitoylation. We named it Pdro for protein associated with DRMs and endosomes.
Very recently, three studies have reported on the same protein under two other names: the human p27RF-Rho that
regulates RhoA activation and actin dynamics, and its rodent orthologue p18 that controls both LE/LY dynamics through
the MERK-ERK pathway and the lysosomal activation of mammalian target of rapamycin complex 1 by amino acids. We
found that, consistent with the presence of sterol-responsive element consensus sequences in the promoter region of
C11orf59, Pdro mRNA and protein expression levels are regulated positively by cellular cholesterol depletion and negatively
by cellular cholesterol loading. Conversely, Pdro is involved in the regulation of cholesterol homeostasis, since its depletion
by siRNA increases cellular free cholesterol content that is accompanied by an increased cholesterol efflux from cells. On the
other hand, cells stably overexpressing Pdro display reduced cellular free cholesterol content. Pdro depletion-mediated
excess cholesterol results, at least in part, from a stimulated low-density lipoprotein (LDL) uptake and an increased
cholesterol egress from LE/LY.
Conclusions/Significance: LDL-derived cholesterol release involves LE/LY motility that is linked to actin dynamics. Because
Pdro regulates these two processes, we propose that modulation of Pdro expression in response to sterol levels regulates
LDL-derived cholesterol through both LDL uptake and LE/LY dynamics, to ultimately control free cholesterol homeostasis.
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Introduction
Cholesterol is essential for maintenance of membrane integrity
and multiple cellular functions. However, excess cholesterol is
toxic and therefore cells maintain their concentration of
cholesterol under tight control [1,2]. Mammalian cells growing
under ordinary culture conditions derive their cholesterol
preferentially from endocytic uptake of low-density lipoproteins
(LDL) present in the serum of the culture medium, and de novo
synthesis in the endoplasmic reticulum (ER) is usually kept
suppressed. Internalized lipoprotein-associated cholesterol esters
are hydrolyzed to free cholesterol in late endosome/lysosome (LE/
LY), from which it is exported to various destinations, including
the plasma membrane and the endoplasmic reticulum. Precisely
how cholesterol egresses from LE/LY remains incompletely
characterized. The Niemman-Pick Type C (NPC) disease, an
inherited lipid storage disorder, is a well-known example of free
cholesterol accumulation in LE/LY [1]. As a result, elevated
cholesterol levels are not counterbalanced by sterol homeostatic
mechanisms in the ER and cholesterol and other lipids continue to
accumulate, causing the formation of abnormal lysosomal storage
organelles. NPC disease is caused by mutations in NPC-1 and -2
proteins located in LE/LY that are believe to coordinate
cholesterol egress from LE/LY, but the precise defect remains
unknown. In addition to a role for NPC proteins, an underlying
cause for cholesterol trafficking defects in NPC may be changes in
the activity of proteins that regulate endosomal motility. LE/LY
exhibit bidirectional motility between the periphery and the
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GTPases. It has been shown that this motility is compromised in
NPC cells and that overexpression of Rab 7 and 9 proteins reduce
the NPC phenotype [3,4]. Much is yet to be learned about
cholesterol trafficking in general. Difficulty in the overall
understanding of intracellular cholesterol movement arises from
the fact that different mechanisms (vesicular and non-vesicular)
operate simultaneously to move cholesterol [1,2]. Therefore,
further description of the protein and lipid factors that control
intracellular cholesterol transport and content are important for a
better understanding of cholesterol homeostasis.
We have previously performed a proteomic analysis of
molecules that associated with detergent-resistant membranes
(DRMs) [5]. This analysis allowed us to identify a novel protein
whose mRNA is ubiquitously expressed. It binds membranes
through N-terminal acylations, and possesses two canonical di-
leucine signals involved in endosome targeting [6]. The protein
was indeed mainly localized in LE/LY. Thus, we have named this
protein Pdro for protein associated with DRMs and endosomes.
While this manuscript was in preparation, two groups reported the
characterization of the same protein. Nada et al, described the
rodent orthologue of Pdro named p18 [7]. Similarly to Pdro, p18
was found to be anchored to DRMs and to localize to LE/LY.
The authors reported that p18 plays an important role in
endosome dynamics by recruiting through binding to p14-MP1,
a scaffold for MEK1, the ERK pathway to LE. More recently, in a
collaborative study, the authors also reported that the p18-p14-
MP1 complex interacts with the Rag GTPases and is necessary for
mammalian target of rapamycin complex 1 (mTORC1) activation
by amino acids [8]. Hoshino et al, on the other hand, described the
human protein named p27RF-Rho [9]. In contrast with our
results and those from Nada et al, p27RF-Rho showed a punctate
distribution that co-localized with punctate actin structure.
p27RF-Rho was demonstrated to bind to p27
kip1 and to regulate
RhoA activation, a small GTPase that is a key regulator of the
actin cytoskeleton [10]. The apparent discrepancy in cellular
localization of Pdro and p18 on one hand, and p27RF-Rho on the
other hand, is unclear at the moment. Thus, these results indicate
a role for Pdro in endocytic trafficking, mTORC1 activation and
actin cytoskeleton dynamics. Interestingly, the endocytic traffick-
ing and the actin dynamics processes are connected, as the actin
cytoskeleton is known to participate to LE/LY dynamics. Indeed,
disrupting filamentous actin results in the redistribution of late
endocytic organelles to the cell periphery, altered endosome
motility and inhibition of cargo degradation [11,12,13,14].
Herein we present evidence that cellular sterol levels regulate
Pdro expression, which in turn affects both LDL-cholesterol
uptake and cholesterol release from LE/LY that likely contribute
to the altered intracellular free cholesterol level. We propose that
the regulatory function of Pdro on cellular cholesterol homeostasis
implicates LE/LY motility that is involved in LDL-derived
cholesterol traffic.
Results and Discussion
Identification and Characterization of Pdro
DRMs from the human neuroblastoma cell line SHEP were
purified as previously described [5] and resolved onto SDS-PAGE
gels. A Coomassie-stained band (apparent molecular weight of
18 kD) excised from the gels was subjected to proteomic analysis
using liquid chromatography and tandem mass spectrometry [5].
Five peptides were sequenced in MSMS mode and the protein
identified corresponds to a protein of 161 amino acids, FLJ20625
(Figure 1A). According to HUGO Gene Nomenclature Commit-
tee, this protein is encoded by gene C11orf59 (chromosome11
open reading frame 59) located at 11q13.4. Complete open
reading frame of the corresponding cDNA was obtained by RT-
PCR from SHEP cells, using primers designed on the basis of the
cDNA sequence available at GenBank/EMBL (accession num-
ber BC001706). The mRNA of Pdro was expressed in various
human tissues (data not shown). A large-scale study reported that
Pdro is myristoylated (Gly2) and palmitoylated (Cys3 and 4) at its
N-terminus [15]. A C-terminus GFP-tagged mutant protein in
which both Cys3 and 4 residues were substituted with Ala residues
(DPdro-GFP) was no longer recovered from DRMs, as compared
with a wild type GFP-tagged protein (Pdro-GFP) and the
endogenous Pdro (Figure 1B). Thus, these modifications serve to
localize Pdro to DRMs.
Very recently, the same human protein named p27RF-Rho and
its rodent orthologue term p18 has been reported [9,7,8].
Intriguingly, p27RF-Rho was localized with punctate actin
structure, whereas rodent p18 was localized to LE/LY. Pdro’s
sequence displays two canonical di-leucine signals between amino
acids 17–22 and 49–54 (Figure 1A, boxed sequences) necessary for
some proteins to be targeted to endosomes [6]. Accordingly, and
consistent with rodent p18 localisation, our results show that Pdro
is associated with the LE/LY compartment. Analysis by confocal
microscopy of SHEP cells stably expressing GFP-tagged Pdro,
showed an extensive co-localization of Pdro-GFP with Lyso-
Tracker Red-positive acidic vesicles (Figure 2A). The distribution
of early endosomal autoantigen 1(EEA1)-positive endosomes did
not match that of Pdro-GFP, whereas Pdro-stained vesicles
colocalized substantially with lysobisphosphatidic acid (LBPA)-
positive LE, and Lysosome-associated membrane protein 1
(LAMP-1)-positive LY. To substantiate further these findings,
cells were allowed to internalize Alexa fluor 488-conjugated
dextran for 2 hours to label LE/LY [16]. Dextran was found to
co-localize with Pdro-labelled structures, which often appeared as
ring-shaped vesicles that include dextran (Figure 2A, inset),
indicating that Pdro associates with the membrane rather than
with the lumen of the lysosomes. The localization of Pdro to LE/
LY depends upon its association with DRMs as the Cys-mutant
(DPdro-GFP) lost the perinuclear LE/LY punctate staining and
appeared more dispersed throughout the cytoplasm (Figure 2B).
Whether DRMs are related to lipid rafts remains unclear. They
cannot be equated with native lipid domains because detergents
can scramble lipids. Nevertheless, DRMs represent a more
ordered membrane environment [17], suggesting that Pdro might
tend to associate with particular lipid domain in LE/LY. Indeed,
endosomes are thought to contain a mosaic of structural and
functional domains [18]. The reason why p27RF-Rho was not
found to localize to LE/LY is unclear at the moment.
Cellular Sterol Levels Regulate Pdro Expression
Examination of the human Pdro promoter reveals that the 2kb
region upstream the transcription start site contains five putative
SRE motifs for SREBP-1/-2 binding (-1441/-1450; -1422/-1431;
-926/-935; -208/-217 and -176/-185, respective to the transcrip-
tion start site). Consistently, it has been recently reported that
SREBPs occupy the promoter region of C11orf59 in a human
hepatocyte cell line [19]. SRE are target sequences for the
transcription factors SREBPs (SRE binding proteins) that regulate
the transcription of numerous genes implicated in cholesterol
homeostasis and fatty acid metabolism [20]. Therefore, Pdro may
not only regulate endocytic trafficking and actin cytoskeleton
dynamic, but it may also play a role in the regulatory circuitry of
lipid homeostasis. Thus we tested whether manipulation of cellular
cholesterol levels that control SREBPs activation [20] could alter
Pdro Affects Cholesterol
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incubating cells with acetylated LDL (AcLDL) in the presence of
lipoprotein-deficient serum [21]. We found that Pdro mRNA
levels, monitored by real time RT-PCR, declined after LDL-
cholesterol loading (Figure 3A). Pdro protein expression levels
were also decreased upon LDL-cholesterol loading (Figure 3B).
Cholesterol depletion was achieved by metabolic inhibition of
cholesterol synthesis in the absence of supplemental sterol, using
compactin [22]. Under these conditions, Pdro mRNA was slightly
increased, whereas its protein expression was more clearly up-
regulated (Figure 3B). This suggests that Pdro expression is further
regulated at translational or post-translational level upon choles-
terol depletion. Together, these results indicate that Pdro
expression is regulated by cellular cholesterol levels. Precise
understanding of the role of SREBPs in the regulation of
C11orf59 expression is currently under investigation.
Pdro Expression Level Alters Cellular Free Cholesterol
Content
As mentioned earlier, mammalian cells growing under ordinary
culture conditions derive their cholesterol preferentially from
endocytic uptake of lipoproteins. Because Pdro localizes in LE/LY
from which cholesterol derived from low-density lipoprotein
egresses, we tested whether overexpression or depletion of Pdro
could alter cellular free cholesterol content. We designed small
interfering RNA (siPdro) that was able to substantially knock-down
expression of endogenous Pdro (Figure 3C). Total cellular free
cholesterol content was evaluated using flow cytometry analysis of
filipin staining, a fluorescent marker for unesterified cholesterol.
Our results demonstrated a ,2 fold increase in cellular free
cholesterol level in cells treated for 72 h with siPdro under
ordinary culture conditions (Table 1). However, binding of FITC-
wheat germ agglutinin lectin to cell surface glycoproteins and
glycolipids remained unaltered, suggesting that Pdro depletion did
not result in general cellular modification. To further substantiate
the validity of the filipin staining analysis, the results from this
technique were compared with those obtained by gas chromato-
graphic analysis of free cholesterol content of cellular lysates. Both
techniques yielded similar results (Table 1). Therefore, Pdro
depletion increases cellular free cholesterol. Conversely, cells
overexpressing a V5-tagged Pdro displayed a reduced level of
cellular free cholesterol content, as compared to parental cells
(SHEP: 12.363.42 mg/mg protein; SHEP-Pdro-V5:
3.9161.21 mg/mg protein. Values are mean 6 SD. n=3,
p#0.05 using Mann Whitney test). This latter result also argues
against an off-target effect of siPdro sequence. Finally, the effect of
Pdro level on cholesterol was verified to be independent of cell
confluence (data not shown). Thus, the expression levels of Pdro
alter cellular free cholesterol content, indicating that Pdro
participates in the regulatory circuitry of cholesterol homeostasis.
Depletion of Pdro Increases Cholesterol Release from LE/
LY
The rodent orthologue of Pdro has been involved in controlling
LE/LY dynamics [7], which in turn may affect LDL-derived
cholesterol egress, as suggested in NPC disease [3,4]. In this
disease, the increased cellular free cholesterol content results form
a lysosomal accumulation of LDL-derived cholesterol that causes
the formation of abnormal lysosomal storage organelles [1]. Thus,
we undertook confocal microscopy analysis of cellular filipin
staining to investigate whether Pdro depletion has altered cellular
free cholesterol distribution. In control cells, filipin staining was
Figure 1. Identification and characterization of Pdro. (A) Full-length amino acid sequences of Pdro. Underlined amino acids indicate the
position of peptide sequences determined by LC-MS/MS, boxes correspond to di-leucine motif (D/EXXXLL), stars indicate palmitoylation and
myristoylation sites (C3 and 4 and G2 respectively). (B) DRMs from cells stably expressing Pdro-GFP (a c-terminus GFP-tagged protein) or DPdro-GFP
(a c-terminus GFP-tagged mutant protein in which both Cys2 and 3 residues were substituted with Ala residues) were separated on a bottom-loaded
sucrose step gradient. Probing the membrane with anti-GFP, anti-Pdro, anti-flotillin (DRMs marker) or anti-transferrin receptor (TfR, non-DRMs marker)
antibodies assessed the distribution of proteins within fractions. Molecular–size standards (in kD) are shown on the left of the panel. The numbers
represent the different fractions of the gradient.
doi:10.1371/journal.pone.0010977.g001
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work and on plasma membrane projections such as lamellipodia
(Figure 4A). Visualization of cell surface membranous structures is
likely facilitated by membrane convolution that generates an
increase in fluorescence intensity [23]. This staining is consistent
with the expected normal free cholesterol distribution, which
includes enrichment in the plasma membrane, certain endosomes
and part of the Golgi complex [2]. SiPdro-treated cells often
appeared more spread than control-treated cells and they
displayed an increase in filipin-stained membrane ruffles (arrow)
and filopodia (arrow head). These membrane protrusions may
result from elevated plasma membrane cholesterol content due to
the increased cellular free cholesterol levels. Indeed, elevated
membrane cholesterol causes an increase in membrane ruffling
possibly through a misregulation of Rac GTPase [24]. They may
also be a consequence of the depleted regulatory function of Pdro
on RhoA GTPase activation [9], as the Rho GTPases are thought
to exert mutual regulation to coordinate cytoskeletal behavior
[25]. Nonetheless, neither an accumulation nor a decrease of
cholesterol in the perinuclear network was readily observed. These
data indicate that in contrast with NPC disease, Pdro depletion
does not result in cholesterol accumulation in LE/LY.
We then asked whether the intracellular trafficking of the
cholesterol released from LE/LY could be altered upon Pdro
depletion. This released cholesterol moves to various destinations
including the plasma membrane and the ER [26]. Esterification by
Figure 2. Intracellular localization of Pdro. (A) Pdro-GFP (green) expressing SHEP cells were either incubated with Lysotracker for 30 min and
fixed before mounting, or fixed, permeabilized, and incubated with antibodies to EEA-1, LBPA and Lamp-1 to label endosomal compartments. For LE/
LY labelling with Dextran, Pdro-GFP expressing SHEP cells were incubated with Alexa Fluor 488 Dextran. Co-distribution was assessed by confocal
microscopy and is visualized in yellow in the merged images. Boxed areas are shown magnified. Scale bar=10 mm. (B) Immunofluorescence images
show intracellular localization of Pdro in SHEP cell lines stably expressing Pdro-GFP, and DPdro-GFP using antibodies directed to GFP. Scale
bar=10 mm. Cellular lysates from these cell lines were subjected to SDS-PAGE and immunoblotted with antibodies against GFP tag (Right panel).
Molecular size standards (in kD) are shown on the left of the panel.
doi:10.1371/journal.pone.0010977.g002
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(ACAT) is often used as an assay for LDL-derived cholesterol to
ER transport. It remains unclear however, whether most LDL-
derived cholesterol transits through the plasma membrane before
reaching the ER, or whether it can move directly to the ER [26].
To test whether Pdro depletion could interfere with cholesterol
trafficking and correct delivery to the ER, we investigated
cholesterol esterification by measuring incorporation of [
3H]oleate
into cholesteryl esters [27]. This was performed in lipoprotein-
deficient serum in the presence or absence of 100 mg/ml of
AcLDL, which is known to stimulate cholesterol esterification [28].
We found that in the absence of AcLDL, cellular cholesterol
esterification rate was low in SHEP cells and only slightly affected
following depletion of Pdro (Figure 4B). In contrast, in the
presence of AcLDL, incorporation of [
3H]oleate into cholesteryl
esters was strongly increased. Upon Pdro depletion, AcLDL-
stimulated cholesterol esterification was further augmented. In
Figure 3. Cellular sterol levels regulate Pdro expression. (A) Manipulation of cellular cholesterol levels were performed by treating cells with
the indicated AcLDL concentrations for 24h to stimulate cholesterol loading, or using the indicated concentrations of compactin for 24h to reduce
cellular cholesterol. Pdro mRNA levels quantified by real-time PCR are expressed as relative units after internal normalization to TBP mRNA levels and
compared with control samples in the absence of treatment. Values represent the mean 6 SD of three independent experiments (*, p#0.05 using
Mann Whitney test). (B) Cellular lysates from these AcLDL or compactin treated cells were subjected to SDS-PAGE and immunoblotted with
antibodies against endogenous Pdro. Actin served as loading controls. (C) SHEP cells were treated with siPdro or a control scramble siRNA (scramble).
After 72h, cellular lysates were analyzed for Pdro mRNA content by Northern Blotting (mRNA) or for Pdro (protein) content by immunoblotting using
anti-Pdro antibody. Actin served as loading controls.
doi:10.1371/journal.pone.0010977.g003
Table 1. Pdro knockdown increases cellular cholesterol
content.
Scramble SiPdro
Filipin intensity (arbitrary units)
a 432.3361.61 811.12±61.49*
FITC-WGA fluorescence (arbitrary units)
a 117.1466.75 121.7461.64
Free cholesterol (mg/mg protein)
b 3.2560.93 6.27±1.48*
a: Filipin and FITC-WGA labelling of the cells was quantified by flow cytometry
(arbitrary units of fluorescence intensity).
b: Free cholesterol was quantified by gas chromatographic analysis after
separation of cellular lipids by TLC. Values are mean 6 SD of three independent
experiments en triplicate wells.
*p#0.05 using Mann Whitney test.
doi:10.1371/journal.pone.0010977.t001
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LDL cholesterol. However, the augmentation observed upon Pdro
depletion mostly represents esterification of LDL-derived choles-
terol, since in the absence of LDL (when only cellular cholesterol is
present), cholesterol esterification was rather slightly diminished by
the depletion of Pdro. These results strongly suggest that
cholesterol flux between LE/LY and the ER is increased when
Pdro is depleted. It is also consistent with the absence of
cholesterol accumulation in the perinuclear network described in
Figure 4A.
Depletion of Pdro Stimulates Both LDL Uptake and
Cholesterol Efflux from Cells
One mechanism that could contribute to increased cholesterol
egress from LE/LY is an enhanced uptake of LDL. To test this
hypothesis, control cells or cells depleted for Pdro were incubated
with [
3H]cholesteryl oleate-labeled LDL for 12 hours, and total
radioactivity in cell homogenates was counted. As shown in Fig 5A,
the uptake of LDL was significantly increased upon Pdro
depletion, suggesting that the increase in free cellular cholesterol
is due, at least in part, to an increased LDL uptake followed by an
increased cholesterol egress from LE/LY. The LDL preparations
used for uptake assay are modified LDL that are internalized
through Scavenger Receptors or through non-receptor mediated
fluid-phase macropinocytosis [29]. Considering that the plasma
membrane protrusions described in Figure 4A are often associated
with macropinocytic activity [30], we investigate whether Pdro
knockdown could stimulate macropinocytosis. Control- or siPdro-
treated cells were incubated with RITC-conjugated dextran and
macropinocytic activity was analyzed by flow cytometry. Figure 5B
shows that the amount of fluorescent dextran taken up by the cells
was significantly increased upon knockdown of Pdro. Therefore,
the absence of Pdro stimulates an increased macropinocytosis that
may contribute to LDL uptake. The relative contribution of
Scavenger Receptors and macropinocytosis in the increased LDL
uptake is currently being investigated.
Excess cellular cholesterol is converted into nontoxic cholesteryl
ester for storage or removed by cholesterol efflux at the plasma
membrane [26]. In addition to the increased esterification
depicted in Figure 4B, we examined whether cholesterol efflux
was also increased upon Pdro knockdown. We therefore
monitored the incorporation of [
3H]cholesterol from radiolabeled
cells into lipid-poor apoliprotein A-1 (apoA-1) [31]. ApoA-1 binds
to the ubiquitously expressed ABC transporter A1, and triggers a
multi-step process by which cholesterol is transferred from the
plasma membrane to apoA-1 to generate disk-like high-density
lipoprotein (HDL). Depletion of Pdro resulted in a clear increase
in cholesterol efflux as compared with cells treated with control
siRNA (Figure 5C). These data indicate that upon depletion of
Pdro, the excess cholesterol is accompanied by an increase in
cholesterol efflux from cells, possibly to prevent an over-
accumulation of free cholesterol that is toxic to cells.
Figure 4. Pdro knockdown increases plasma membrane projections and cholesterol esterification. (A) Images of Filipin staining of SHEP
cells treated for 72h with siPdro or scramble siRNA. Cholesterol-rich plasma membrane ruffles are indicated by arrows and filipodia by arrowheads. (B)
Rate of cholesterol esterification in SHEP cells pre-treated for 72h with the indicated siRNA, followed by loading or not with 100 mg/ml AcLDL for 8h in
the presence of [
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Alterations in cholesterol and lipids contribute to certain
diseases including atherosclerotic foam cells and Niemann-Pick
type C disease. Recent progress in the understanding of the
molecular basis of these disorders has arisen from the identification
of proteins that control cholesterol transport and consequently
affect cellular cholesterol content, such as Niemman-Pick Type C
proteins or ABCA1 [1,2]. In the present report, we reveal a role
for the LE/LY-localized Pdro protein in the regulatory circuitry of
cholesterol content. Cellular sterol levels regulate Pdro expression
that in turn affects cellular cholesterol content. We revealed that
Pdro depletion stimulated both LDL uptake and cholesterol
release from LE/LY, providing a rationale to explain the
increased free cellular cholesterol content observed upon Pdro
knockdown. p18 has been reported to be essential for amino acid
signalling to mTORC1 [8]. Whether an alteration of the
mTORC1 signalling pathway could participate in the modulation
of free cholesterol levels we describe here, is unclear at the
moment and deserves further studies. On the other hand, the
reported alteration in LE/LY dynamics upon p18 depletion could
more directly participate in the increased LDL-derived cholesterol
flux. p18 depletion results in the redistribution of LE/LY to the
cell periphery [7]. It is noteworthy that depletion of p27-RF
interferes with the formation of actin stress fibers [9], and that
disruption of filamentous actin also results in LE/LY scattering
[12,13,14]. Because LE/LY motility can affect cholesterol
trafficking [3,4], Pdro depletion might also alter LDL-derived
cholesterol release independently of LDL uptake. Thus, by
regulating the expression level of Pdro through their sterols levels,
cells may engage a mechanism that regulates both LDL uptake




The antibodies used and their sources are as follow: Peroxidase-
conjugated goat anti-mouse or anti-rabbit IgG, and Cy3 or Cy5-
conjugated donkey anti-mouse IgG were from Jackson Immu-
noResearch. Anti-LBPA antibody was a generous gift from Dr T.
Kobayashi. The antibodies for EEA1 (clone 14) and Flotillin-2
(clone 29) were from BD Transduction Laboratories. The
antibody for lamp-1 (clone H4A3) was from Developmental
Studies Hybridoma Bank and for GFP from Roche Diagnostics.
Lysotracker red DND-99, Alexa Fluor 488-labeled Dextran were
from Molecular Probes. Filipin III was from Cayman chemicals.
Geneticin, Lipofectamine 2000 were from Invitrogen. Rabbit anti-
Pdro antibody and SiRNAs were developed by Eurogentec.
Mass Spectrometry Identification
A discrete band was excised from the Coomassie blue-stained
gel and in-gel digested as previously described [32]. Gel pieces
Figure 5. Pdro knockdown stimulates LDL uptake, macropinocytosis and cholesterol efflux. (A) For LDL uptake, cells pre-treated for 72h
with the indicated siRNA and further incubated for 12h with [
3H] cholesteryl oleate-labelled AcLDL (50 mg/ml) in lipoprotein lipoprotein-deficient
serum. (B) For macropinocytosis determination, cells pre-treated for 72h with the indicated siRNA were incubated or not with RITC-dextran (2.5mg/
ml) for various time, extensively washed and fixed with 4% PFA, and analyzed by flow cytometry. Values are compared with control samples in with
RITC-dextran was omitted. (C) Cholesterol efflux to apoA-1 during 18h from SHEP was determined by incubating cells pre-treated for 72h with the
indicated siRNA, with [
3H] cholesterol and further incubation in serum-free medium containing 0.2% bovine serum albumin in the presence or
absence of 10mg/ml apoA-I. Values are expressed as percentage of cholesterol efflux. Values represent the mean 6 SD of three independent
experiments (*, p#0.05 using Mann Whitney test).
doi:10.1371/journal.pone.0010977.g005
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acetonitrile. After drying, tryptic peptides were resuspended in
0.5% aqueous trifluoroacetic acid. The samples were injected into
a LC-Packings (Dionex) nanoLC system and first preconcentrated
on a 300 mm65 mm PepMap C18 precolumn. The peptides were
then eluted onto a C18 column (75 mm6150 mm). The
chromatographic separation used a gradient from solution A
(5% acetonitrile: 95% water: 0.1% formic acid) to solution B (95%
acetonitrile: 5% water: 0.1% formic acid) over 60 min at a flow
rate of 300 nL6min
21. The LC system was directly coupled to a
QTOF Ultima mass spectrometer (Waters). MS and MS/MS data
were acquired and processed automatically using MassLynx 3.5
software. MS/MS data were processed using Mascot Distiller to
produce peak lists that were subsequently submitted to the Mascot
1.8 (Matrix Science, UK) search engine for database search.
Searches were performed against the NCBInr (20021102)
database with the taxonomy ‘‘Mammalia’’. Five distinct peptides
corresponded to the Pdro protein. Four peptides have been
identified with a score higher than 50 and the last one was checked
manually.
Transfection and Biochemistry Procedures
SHEP cells, maintained in RPMI (Sigma) containing 10% fetal
bovine serum and antibiotics, were transfected (2 mg/ml of the
plasmid) using Lipofectamine 2000 and selected using Geneticin
(1mg/ml) for stable expression. SiRNA were transfected using
Lipofectamine 2000 and 0.125nM siRNA duplexes: Si-Pdro, 59-
GGAGCUGGUUGUACAGUUU-39; scramble siRNA was from
Dharmacon. Cells were processed for immunoblotting, immuno-
fluorescence or northern blotting 72h after transfection. Cellular
lysates were done at 4uC using modified RIPA 16(50 mM Tris-
HCl pH 7.4, 1% NP40, 0.25% sodium deoxycholate, 150 mM
NaCl, 1 mM EDTA, 1 mM NaOVO4, 1 mM NaF and protease
inhibitors). Immunoprecipitation and Western blotting were
performed as previously described [33] except that sodium
deoxycholate was omitted from RIPA. DRMs purification was
performed as described in [5].
Cloning, Plasmids, Tissue Expression, Nothern Blotting
and Real-Time RT-PCR
Complete open reading frame of the cDNA (GenBank/EMBL
accession number BC001706, 1060bp cDNA, approximately
1300 bp mRNA), was obtained by RT-PCR from SHEP cells,
using primers (59-ACCATGGGGTGCTGCACAG-39 and 59-
TGGGATCCCAAACTGTACAAC-39), and cloned into
pDONR221 or pcDNA-DEST47 (GFP tag) or pcDNA-DEST40
(V5 tag) following manufacturer’s instructions (Gateway Technol-
ogy, Invitrogen). Cys3 and 4 and Gly2 residues were mutated to
alanines using QuickChange XL Site-directed mutagenesis Kit
(Stratagene). Detection of Pdro mRNA expression in human
tissues (Total RNAs from BD Biosciences) was done by RT-PCR
using the above primers. GAPDH primers were used in the PCR
as a control. Northern Blotting was performed as described by
Anczukow et al. [34] using [
32P] labeled cDNA of Pdro and actin
as probes. For quantification of mRNAs by real-time RT-PCR,
total RNA from SHEP cells was isolated using the Trizol reagent
(Invitrogen, Courtaboeuf, France) according to manufacturer’s
instructions. First-strand cDNAs were synthesized from 500 ng of
total RNA in the presence of 100 U of Superscript II (Invitrogen)
and a mixture of random hexamers and oligo(dT) primers
(Promega). Real-time PCR assays were performed with Rotor-
GeneTM 6000 (Corbett Research, Mortlake, Australia). A list of
the primers and real-time PCR assay conditions are available upon
request (lefai@univ-lyon1.fr). The results were normalized using
TBP (TATA binding protein) mRNA concentration, measured as
reference gene in each sample.
Immunofluorescence and Flow Cytometry Analysis
Immunostaining and dextran internalization was performed as
described by Kauppi et al. [16]. Primary antibodies used to label
endosomal compartment were revealed by incubation with Cy5-
Conjugated anti-mouse secondary antibodies. Filipin staining of
cholesterol was performed as described [35]. Cells were examined
under a Leica TCS-SP confocal microscope equipped with an
argon laser for UV excitations, and sections were constructed with
Leica Confocal Software. Fluorescence signals were recorded
sequentially using a 636 Plan-NEOFLUAR oil immersion
objective. Images were processed for contrast and brightness
using Photoshop (v8.0.1). Flow cytometry analysis of FITC-WGA
were performed as described in [36] using a FACS Vantage SE
(Becton Dickinson).
Preparation of LDL and Determination of LDL Uptake and
Macropinocytosis
Human LDLs were isolated from plasma by sequential
ultracentrifugation. LDLs were acetylated with acetic anhydride
by the method of Basu et al. [37]. Determination of LDL uptake
was performed as previously decribed [27]. Briefly, LDLs were
first labelled with [
3H] cholesteryl oleate and re-isolated by
ultracentrifugation before acetylation with acetic anhydride. Cells
were then incubated for 12h with labelled-AcLDL in the presence
of lipoprotein-deficient serum, lysed in 0.1% Triton and
radioactivity determined by liquid scintillation counting. Total
uptake was calculated as dpm/mg cell protein. For macropino-
cytosis quantification, cells were serum starved for 2 hours and
incubated at 37uC in the presence of Rhodamine B-isothiocyanate
(RITC)-dextran (2.5mg/ml) for various time. To terminate
dextran uptake, cells were transferred to ice, washed three times
with ice-cold PBS and fixed with 4% PFA (30 min at 4uC). Gently
scrapped cells were resuspended in PBS and analysed by flow
cytometry.
Determination of Cholesterol Content, Cholesterol
Esterification and Efflux
Cellular free cholesterol mass was determined as previously
described [27]. Briefly, total lipids extracted from cell lysates were
separated by thin layer chromatography. The silica gel containing
free cholesterol was scraped, and analyzed by gas chromatogra-
phy using an Econo-Cap EC-5 capillary column (30 m60.32 mm,
0.25 mm) with helium as the carrier gas and quantified using
stigmasterol as the internal standard. Free cholesterol determined
by filipin intensity was performed by flow cytometry as described
by Berger et al. [38]. Determination of cholesterol esterification
was performed by quantification of [
3H]oleate (0.5 mCi/ml)
incorporation into cholesteryl ester for 8 hours in lipoprotein-
deficient serum, in the presence or absence of AcLDL (100mg/
ml), as previously described [27]. For determination of cholesterol
efflux, cells were incubated in the presence of [
3H] cholesterol
(2mCi/ml) for 18h, washed three times with PBS and incubated in
serum-free medium supplemented with 0.2% bovine serum
albumin with or without 10mg/ml apoA-I for 18h. The medium
and cells were collected separately, and radioactivity was
determined by liquid scintillation counting. The percent choles-
terol efflux was calculated as [
3H]cholesterol counts in the
medium divided by the sum of [
3H] counts in the cell and in the
medium.
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